340 related articles for article (PubMed ID: 23035860)
1. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies.
Lau TK; Jiang F; Chan MK; Zhang H; Lo PS; Wang W
J Matern Fetal Neonatal Med; 2013 Mar; 26(4):434-7. PubMed ID: 23035860
[TBL] [Abstract][Full Text] [Related]
2. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
Prats P; Rodríguez I; Comas C; Puerto B
Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
[TBL] [Abstract][Full Text] [Related]
3. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
4. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement?
Goncé A; Borrell A; Fortuny A; Casals E; Martínez MA; Mercadé I; Cararach V; Vanrell JA
Prenat Diagn; 2005 Dec; 25(12):1156-61. PubMed ID: 16231401
[TBL] [Abstract][Full Text] [Related]
5. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
6. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
7. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
[TBL] [Abstract][Full Text] [Related]
8. [Cell-free fetal DNA analysis in maternal plasma as a screening test for trisomy 21 in twin pregnancies].
Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
Gynecol Obstet Fertil Senol; 2018; 46(7-8):580-586. PubMed ID: 29929941
[TBL] [Abstract][Full Text] [Related]
9. Massively Parallel Sequencing (MPS) of Cell-Free Fetal DNA (cffDNA) for Trisomies 21, 18, and 13 in Twin Pregnancies.
Du E; Feng C; Cao Y; Yao Y; Lu J; Zhang Y
Twin Res Hum Genet; 2017 Jun; 20(3):242-249. PubMed ID: 28485265
[TBL] [Abstract][Full Text] [Related]
10. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis in multiple pregnancy.
Taylor MJ; Fisk NM
Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Aug; 14(4):663-75. PubMed ID: 10985937
[TBL] [Abstract][Full Text] [Related]
12. Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies.
Bevilacqua E; Gil MM; Nicolaides KH; Ordoñez E; Cirigliano V; Dierickx H; Willems PJ; Jani JC
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):61-6. PubMed ID: 25297464
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive chromosome test raises new questions in prenatal diagnosis about the significance of ultrasound and questions about new screening strategies.
Tercanli S; Vial Y; Merz E
Ultraschall Med; 2013 Oct; 34(5):417-20. PubMed ID: 24127381
[No Abstract] [Full Text] [Related]
14. Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing.
Leung TY; Qu JZ; Liao GJ; Jiang P; Cheng YK; Chan KC; Chiu RW; Lo YM
Prenat Diagn; 2013 Jul; 33(7):675-81. PubMed ID: 23595772
[TBL] [Abstract][Full Text] [Related]
15. Multiple marker screening for Down syndrome in twin pregnancies.
Neveux LM; Palomaki GE; Knight GJ; Haddow JE
Prenat Diagn; 1996 Jan; 16(1):29-34. PubMed ID: 8821849
[TBL] [Abstract][Full Text] [Related]
16. Prenatal diagnosis of trisomy 21 in monozygotic twins with increased nuchal translucency and abnormal serum biochemistry.
Verdin SM; Braithwaite JM; Spencer K; Economides DL
Fetal Diagn Ther; 1997; 12(3):153-5. PubMed ID: 9313073
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies.
Huang X; Zheng J; Chen M; Zhao Y; Zhang C; Liu L; Xie W; Shi S; Wei Y; Lei D; Xu C; Wu Q; Guo X; Shi X; Zhou Y; Liu Q; Gao Y; Jiang F; Zhang H; Su F; Ge H; Li X; Pan X; Chen S; Chen F; Fang Q; Jiang H; Lau TK; Wang W
Prenat Diagn; 2014 Apr; 34(4):335-40. PubMed ID: 24357023
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.
Lau TK; Chen F; Pan X; Pooh RK; Jiang F; Li Y; Jiang H; Li X; Chen S; Zhang X
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1370-4. PubMed ID: 22070770
[TBL] [Abstract][Full Text] [Related]
19. Down syndrome screening in twins.
Bush MC; Malone FD
Clin Perinatol; 2005 Jun; 32(2):373-86, vi. PubMed ID: 15922788
[TBL] [Abstract][Full Text] [Related]
20. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers.
Spencer K; Kagan KO; Nicolaides KH
Prenat Diagn; 2008 Jan; 28(1):49-52. PubMed ID: 18186136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
